Agile Therapeutics To Participate In The 32nd Annual Piper Sandler Healthcare Conference

PRINCETON, N.J.
Author:
Publish date:

PRINCETON, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a virtual fireside chat at the Piper Sandler 32 nd Annual Healthcare Conference, being held December 1-3, 2020.

The pre-recorded fireside chat is accessible through the Investors section of the Agile Therapeutics website at  https://ir.agiletherapeutics.com/events-and-presentations. The recording will be available at 10:00am ET today through Thursday, December 3, 2020.

About Agile Therapeutics, Inc.Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today's women.  Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.  Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at  www.agiletherapeutics.com . The Company may occasionally disseminate material, nonpublic information on the Company's website.

Follow Agile on  LinkedIn  and Twitter:  @AgileTher .

Contact:  Matt RileyHead of Investor Relations & Corporate Communications mriley@agiletherapeutics.com